Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients

被引:4
|
作者
Volteas, Panagiotis [1 ]
Drakos, Panagiotis [1 ]
Alkadaa, Leor N. [2 ]
Cleri, Nathaniel A. [2 ]
Asencio, Anthony A. [2 ]
Oganov, Anthony [2 ]
Giannopoulos, Stefanos [1 ,3 ]
Saadon, Jordan R. [2 ]
Mikell, Charles B., III [2 ]
Rubano, Jerry A. [1 ]
Labropoulos, Nicos [3 ]
Tassiopoulos, Apostolos K. [1 ,3 ]
Mofakham, Sima [2 ]
Bannazadeh, Mohsen [1 ,3 ]
机构
[1] Renaissance Sch Med, Dept Surg, Stony Brook, NY USA
[2] Renaissance Sch Med, Dept Neurosurg, Stony Brook, NY USA
[3] Renaissance Sch Med, Div Vasc Surg, Dept Surg, Stony Brook, NY USA
关键词
COVID-19; SARS-CoV-2; Low-molecular-weight heparin (LMWH); Unfractionated heparin (UFH); Thromboprophylaxis; Anticoagulation (AC); ANTICOAGULATION; ENOXAPARIN;
D O I
10.1016/j.jvsv.2022.04.019
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Thrombosis in COVID-19 worsens mortality. In our study, we sought to investigate how the dose and type of anticoagulation (AC) can influence patient outcomes. Methods: This is a single-center retrospective analysis of critically ill intubated patients with COVID-19, comparing low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) at therapeutic and prophylactic doses. Of 218 patients, 135 received LMWH (70 prophylactic, 65 therapeutic) and 83 UFH (11 prophylactic, 72 therapeutic). The primary outcome was mortality. Secondary outcomes were thromboembolic complications confirmed on imaging and major bleeding complications. Cox proportional-hazards regression models were used to determine whether the type and dose of AC were independent predictors of survival. We performed Kaplan-Meier survival analysis to compare the cumulative survivals. Results: Overall, therapeutic AC, with either LMWH (65% vs 79%, P = .09) or UFH (32% vs 46%, P = .73), conveyed no survival benefit over prophylactic AC. UFH was associated with a higher mortality rate than LMWH (66% vs 28%, P= .001), which was also evident in the multivariable analysis (LMWH vs UFH mortality, hazard ratio: 0.47, P = .001) and in the Kaplan-Meier survival analysis. Thrombotic and bleeding complications did not depend on the AC type (prophylactic LMWH vs UFH: thrombosis P = .49, bleeding P = .075; therapeutic LMWH vs UFH: thrombosis P = .5, bleeding P = .17). When comparing prophylactic with therapeutic AC, the rate of both thrombotic and bleeding complications was higher with the use of LMWH compared with UFH. In addition, transfusion requirements were significantly higher with both therapeutic LMWH and UFH. Conclusions: Among intubated critically ill COVID-19 intensive care unit patients, therapeutic AC, with either LMWH or UFH, conveyed no survival benefit over prophylactic AC. AC with LMWH was associated with higher cumulative survival compared with AC with UFH.
引用
收藏
页码:1128 / 1136
页数:9
相关论文
共 50 条
  • [11] Use of low-molecular-weight heparin in COVID-19 patients Reply
    Marone, Enrico M.
    Rinaldi, Luigi F.
    [J]. JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2020, 8 (05) : 901 - 901
  • [12] A LOW-MOLECULAR WEIGHT HEPARIN COMPARED WITH UNFRACTIONATED HEPARIN
    THOMAS, DP
    MERTON, RE
    [J]. THROMBOSIS RESEARCH, 1982, 28 (03) : 343 - 350
  • [13] Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients
    Stattin, K.
    Lipcsey, M.
    Andersson, H.
    Ponten, E.
    Anderberg, S. Bulow
    Gradin, A.
    Larsson, A.
    Lubenow, N.
    von Seth, M.
    Rubertsson, S.
    Hultstrom, M.
    Frithiof, R.
    [J]. JOURNAL OF CRITICAL CARE, 2020, 60 : 249 - 252
  • [14] HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENTS TREATED WITH LOW-MOLECULAR-WEIGHT HEPARIN OR UNFRACTIONATED HEPARIN
    WARKENTIN, TE
    LEVINE, MN
    HIRSH, J
    HORSEWOOD, P
    ROBERTS, RS
    GENT, M
    KELTON, JG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20): : 1330 - 1335
  • [15] A comparison of low-molecular-weight and unfractionated heparin
    Kate Matthews
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (3): : 118 - 119
  • [16] Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism
    Bernardi, E
    Prandoni, P
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (05) : 363 - 367
  • [18] A PROSPECTIVE-STUDY OF HEPARIN-INDUCED THROMBOCYTOPENIA - UNFRACTIONATED HEPARIN COMPARED WITH LOW-MOLECULAR-WEIGHT HEPARIN
    WARKENTIN, TE
    LEVINE, MN
    HIRSH, J
    HORSEWOOD, P
    ROBERTS, RS
    GENT, M
    KELTON, JG
    [J]. BLOOD, 1994, 84 (10) : A188 - A188
  • [19] LOW-MOLECULAR-WEIGHT HEPARIN DOSING AND ANTI-XA LEVEL MONITORING IN CRITICALLY ILL COVID-19 ADULTS
    Mioni, Richard
    Latham, Meagan
    Sundaram, Ravi
    Wright, Edward
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 140 - 140
  • [20] Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
    Ida Martinelli
    Alessandro Ciavarella
    Maria Abbattista
    Stefano Aliberti
    Valentina De Zan
    Christian Folli
    Mauro Panigada
    Andrea Gori
    Andrea Artoni
    Anna Maria Ierardi
    Gianpaolo Carrafiello
    Valter Monzani
    Giacomo Grasselli
    Francesco Blasi
    Flora Peyvandi
    [J]. Internal and Emergency Medicine, 2021, 16 : 1223 - 1229